GENE ONLINE|News &
Advanced Biologics & Biosimilars
HanchorBio Partners with Taiwan Cancer Moonshot Project to Advance Next-Generation Precision Immuno-Oncology
2026-08-10
EirGenix Showcases End-to-End Biologics Platform at BIO Asia–Taiwan, Highlighting CDMO Growth
2026-07-27
HanchorBio and InxMed Explore “Barrier Disruption + Myeloid Activation” Strategy for Difficult-to-Treat Solid Tumors
2026-07-08
EirGenix Signs Licensing and Commercialization Agreement with Japanese Pharmaceutical Company for EG1206A in Japan
2026-07-02
Honeybear Biosciences Bringing Total Funds Raised to $34 Million to Accelerate Lead Radiopharmaceutical Candidates into Clinical Trial
2026-06-30
EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026
2026-06-29
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
HanchorBio Presents Next Generation Tri-specific Biologics and Manufacturing Strategies at Biologics World Taiwan 2026
2026-05-14
The Next Decade in Cancer Therapeutics: How Immunotherapy is Evolving from Efficacy to Precision
2026-05-05
Biologics-in-a-Bottle: How 2026’s Drug Pipeline Is Scaling Across Cardio, Neuro, and Immunology
2026-04-21
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
